Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 2 hours ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
BioNTech SE to Post Q1 2024 Earnings of $1.26 Per Share, HC Wainwright Forecasts (NASDAQ:BNTX)
ETF DAILY NEWS· 4 days agoBioNTech SE (NASDAQ:BNTX – Free Report) – Stock analysts at HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for shares of BioNTech ...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
Morningstar· 3 days agoBioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally ...
Brokerages Set BioNTech SE (NASDAQ:BNTX) PT at $120.40
ETF DAILY NEWS· 7 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ten ratings firms that are currently covering the stock, Marketbeat ...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
HC Wainwright Reaffirms “Buy” Rating for BioNTech (NASDAQ:BNTX)
ETF DAILY NEWS· 6 days agoBioNTech (NASDAQ:BNTX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports ...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 20 hours agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...